Freestone Grove Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1M Sell
84,644
-7,078
-8% -$1.58M 0.13% 221
2025
Q4
$15.7M Sell
91,722
-64,188
-41% -$9.98M 0.11% 237
2025
Q3
$20.9M Sell
155,910
-572,412
-79% -$60.6M 0.16% 204
2025
Q2
$70.9M Sell
728,322
-871,408
-54% -$69.1M 0.54% 46
2025
Q1
$116M Buy
1,599,730
+1,240,965
+346% +$97.7M 1.2% 4
2024
Q4
$25.9M Buy
+358,765
New +$27.2M 0.32% 109

Other funds holding LRCX

Freestone Grove Partners's LRCX Position: Q1 2026 in Review

Freestone Grove Partners reduced its Lam Research (LRCX) stake by 7.7% in Q1 2026, selling an estimated $1.58M and leaving 84,644 shares worth $18.1M. The position accounts for 0.13% of the portfolio, ranked #221.

Freestone Grove Partners first reported a position in LRCX in Q4 2024 and has held it in 6 quarters since. The position peaked at $116M in Q1 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Freestone Grove Partners held 84,644 shares of Lam Research worth $18.1M as of Q1 2026.
  • Freestone Grove Partners sold 7,078 Lam Research shares in Q1 2026, an estimated $1.58M.
  • Lam Research made up 0.13% of Freestone Grove Partners's portfolio in Q1 2026, its #221 holding.
  • Freestone Grove Partners first reported a position in Lam Research in Q4 2024 and has held it in 6 quarters since.
  • Freestone Grove Partners's Lam Research position peaked at $116M in Q1 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.